About MRA » Letter from the President
Happy summer! Here’s hoping you are enjoying the longer days and able to spend a bit more time with friends and families doing the things you love. As you take advantage of the warmer weather don’t forget to keep sun safety and our shared goal of defeating melanoma in mind.
At MRA, we are taking advantage of the summer season to accelerate progress for melanoma prevention, detection and treatment. Building on the historic slate of grants we announced last month, we are preparing for our next grant cycle, which will launch in August with a Request for Proposals (RFP). MRA also just released its 2014 Scientific Retreat Report, detailing the extraordinary work of many of our funded investigators and highlighting the collaborative relationships forged at this unique event. You can read the 2014 Scientific Retreat Report here.
It was gratifying to be ranked #1 among 30 premier research grant-making disease foundations by Genetic Engineering & Biotechnology News (GEN). MRA is focused on funding as much cutting-edge melanoma research as possible. Thanks to the generous ongoing support of our founders, MRA allocates 100 percent of all donor dollars directly to research. Check out the full story here.
We are thrilled to be partnering with American Idol® Live! Tour, which began its 40-city run in late June, with $1 from each ticket sold benefitting melanoma research funded by MRA. Also this month, J.Crew is joining with us to promote a message of melanoma awareness and sun safety while raising funds to support research.
MRA’s Chief Science Officer traveled to San Diego, Calif., to attend the 2014 BIO International Conference where the discussion she led about immunotherapies for cancer drew a standing-room only crowd.
Each week brings hopeful news regarding the expanding arsenal of treatment options for melanoma patients. Just this week the first anti-PD1 therapy approval was announced for melanoma patients in Japan. We are excited about these developments, as we see MRA-funded scientists continuing to lead the field in making a real difference in people’s lives. Thank you for your continuing support for our work!
Wendy K.D. Selig
Wendy K.D. Selig
President and CEO
MELANOMA RESEARCH ALLIANCE FOUNDATION (Melanoma Research Alliance; MRA) is a GuideStar Exchange Gold Participant Want to learn more about the GuideStar Exchange?
Click here »